Chicago. The series comprised 50 patients from the Bronchitis Clinic at Hammersmith Hospital and 50 from the Emphysema Clinic at the University of Chicago Hospitals. The patients were men aged between 45 and 65 years with irreversible airway obstruction (forced expiratory volume less than 15 1. in the first second). They were studied by the same standardized clinical and physiological techniques in the two clinics and were found to present a broadly similar range of clinical and physiological abnormality (Fletcher, Jones, Burrows, and Niden, 1964) . We report here the results of yearly studies on these patients during the following three years. The clinical and physiological changes have been compared in the two clinics and in the main clinical types of patient.
METHODS
The patients studied are those described by Burrows, Niden, Fletcher, and Jones (1964) ; in that study they were divided into group A (emphysematous type), group B (bronchial type), and group X (indeterminate type) according to provisional criteria. As a result of a subsequent clinicopathological study (Burrows, Fletcher, Heard, Jones, and Wootliff, 1966) these criteria have been modified to provide a. more accurate prediction of the severity of emphysema. The patients have been regrouped according to the new criteria (Appendix I, p. 334); this results in a larger number of type A and rather fewer type B patients (Table I) , but the incidence of the types remains similar in the two clinics.
Questionnaires were used to obtain the clinical history and were of two types. The first was used at the yearly follow-up appointment and was identical in most respects to the questionnaire used in the original study ; in addition, the 327 (Campbell and Howell, 1960) . The methods used to obtain the initial physiological data have already been described . Serial physiological measurements were subjected to regression analysis. Linear regressions were obtained by the least squares technique with the aid of a high-speed digital computer. Correlations between various physiological and clinical observations were also calculated by the computer.
RESULTS
Slight differences in the time of recruitment in the two clinics led to a difference in the average period of follow-up-34-6 months in London compared to 30 9 months in Chicago but all the patients were followed for at least two years. Although there were some minor omissions in the data collected there were no complete lapses in follow-up; only one patient failed to return for the first yearly follow-up and the two-and threeyear follow-up examinations were attended by all 78 patients who had survived until that time.
DEATHS Eight patients died during the first year, five during the second, and 13 during the third, a total of 26; 12 were London and 14 were Chicago patients. In 19 patients (9 from London, 10 from Chicago) death was directly attributable to the lung disease and in seven patients to other causes (two from cerebrovascular accidents, two from carcinoma, one from myocardial infarction, one post-operatively, and one by suicide). The characteristics of the 19 patients who died from cardiorespiratory causes were broadly similar in the two clinics, allowing for the small numbers. were more short of breath and showed more severe dyspnoea in the step test. Radiographic changes of chronic inflammatory disease, but not of emphysema, were more common than in the remainder. Congestive heart failure occurred more frequently in the patients who died and E.C.G. changes of right ventricular hypertrophy were more common than in the remainder. The F.E.V.1.0 (Fig. 1) and V.C. were lower, as was the total lung capacity (T.L.C.), but the mean diffusing capacity for CO (DL/VA) was the same; the mean mixed venous Pco2 was higher in the patients who died (Fig. 2) . Statistical analysis of the data showed that death was most closely related to the initial Pvco2 (P<0001) but also showed a correlation with the initial V.C. (P<0-05) and F.E.V.1.0 (P<0-05); stepwise multiple regression showed that after the Pco2 had been taken into account neither F.E.V.1.0 nor V.C. were significantly correlated with death; in contrast, the relationship between death and Pvco, was still significant even after the F.E.V.1.0 and V.C. had been considered.
CHANGES IN SYMPTOMS
Some patients who showed an apparent change for the better or for the worse when their answers to questions about the present severity of symptoms were compared with their answers in previous years, answered the question as to whether they were 'better' or 'worse' in these respects in a contrary sense. Responses to both types of questions were examined; when the answers were contradictory it was assumed that no significant change in the symptom had occurred.
Comparing the clinical course in the two clinics (Table III) , it was found that Chicago patients more frequently claimed improvement in cough and sputum production but admitted to increasing breathlessness more often than London patients. These differences were not supported by measurements of sputum volume, assessment of dyspnoea in the step test, or measurement of F.E.V.1.0, all of which showed similar progression in the two clinics. Patients often reported an improvement in sputum production without showing any change in measured 24-hour sputum volume (Table IVA) . Deterioration in symptomatic breathlessness during the follow-up period was significantly correlated (r= +0 387; P<0 001) with deterioration in ability to perform the step test (Table IVB) (Table VIII) . This finding could not be related entirely to the degree of airway obstruction as indicated by the F.E.V.1.0; even when patients with an F.E.V.1.0 of less than 1 litre were considered (Fig. 1 ) the death rate was higher in group B than in the other groups and appeared to be similarly related to F.E.V.1.0 in all three types. The relation between death and the initial PvCO2 has already been mentioned (Fig. 2) stepwise regression showed that after the Pi'co2 had been considered there was no significant correlation with the type of patient. Chronic or recurrent heart failure had been present in four of the nine type B patients who Hg or more. Apart from these differences the clinical types of patient behaved in a very similar way during the follow-up period. The slight differences between the types in the progression of symptoms and of pulmonary function abnormalities were not significant.
DISCUSSION
The mortality rate found in this study 26% over a three-year period-is approximately four times higher than that expected in the general population of England and Wales (Registrar General's S.atistical Revi-ew, 1964) . It is similar to the report by Oswald, Medvei, and Waller (1967) patients who died of their respiratory disease showed considerable overlap with those of the survivors, but these patients tended to be more short of breath with a lower average F.E.V.1.,, (Fig. 1 ), higher average Pvco2 (Fig. 2) , and a greater incidence of congestive heart failure and of electrocardiographic and radiographic abnormality. The relationship between blood gas changes and cor pulmonale has previously been reported by Platts and Greaves (1957) In considering changes in symptoms, it must be remembered that patients who died have been excluded from our analysis unless they were still alive after two to three years. During the followup period neither cough nor sputum production changed much. About 40% became more breathless either symptomatically or as judged by the step test (Table III) , and in 15% deterioration was noted in both symptoms and performance (Table  IV) . In most patients an increase in breathlessness was accompanied by a decrease in ventilatory capacity, being significantly related to a fall in F.E.V.1.0 (P<0-001). Change in observed exercise dyspnoea correlated with decrease of F.E.V..) (P<0-001), but also correlated with decrease of V.C. (P<0-01) and increase of Pivco2 (P<0-05).
In a small number of patients (7 to 10%) an improvement occurred in symptoms, observed dyspnoea, and ventilatory capacity. In some, this was due to control of bronchial infection but in others it may have been due to random variation in disability and pulmonary function; it does not appear to be due merely to the beneficial effect which might be expected after enrolment in a special clinic, for nearly all the patients had been attending the same clinic for some years before the study began. There is no doubt that even at this advanced stage a few patients will be found to improve.
Oedema was noted for the first time during the follow-up period by 18 patients in whom it had been absent initially (Table III ). An increase in heart size in the chest radiograph was found in four of these-.patients, but an increase in electrocardiographic signs of right ventricular hypertrophy in only one; these changes occurred with almost equal frequency in patients who did not develop oedema.
It is well known that cessation of smoking will often lead to clinical improvement in patients with chronic airway obstruction. A large proportion of our patients had stopped smoking before the study began and almost all had cut their consumption to a low level; those who stopped during the study showed similar progress to those who continued, but the small numbers make it impossible to draw any general conclusions regarding the effects of stopping smoking small numbers of cigarettes.
Few changes in the radiographic appearances were seen: in their study of a large number of patients, Simon and Medvei (1962) drew attention to the lack of progression in radiographic appearances and were unable to find any patient who developed radiological changes of emphysema during a five-year period.
Although considerable variation was found, there was on average a yearly decline in V.C. of 0-12 1. and in the F.E.V.1.0 of 0-046 litre. The latter figure is less than that found by the Medical Research Council's working party (1966) (Burrows, Niden, Barclay, and Kasik, 1965) . Previous retrospective studies of changes in pulmonary function in patients with chronic airway obstruction have shown little change in lung volumes and blood gases; however, Boushy and Lewis (1964) and Sukumalchantra and Williams (1965) reported that small but significant changes occurred in diffusing capacity over several years. Single-breath DLCO was measured during the study in the 38 surviving Chicago patients; the average fall over two to three years was 2-6 ml./min./ mm. Hg, and 11 patients showed a fall of over 5 ml./min./mm. Hg during the follow-up period; DL/VA, the diffusing capacity per litre of lung volume, fell on average by 0 37 ml./min./mm. Hg/l.; these figures are in agreement with those of previous reports which used steady-state methods for measuring DLCO. No consistent relation could be found between the fall in DLCO and a fall in FEV.,. or V.C. in individual patients.
In most respects the patients in the two cities showed a similar progression during the study, confirming the similarity of patients with irreversible airway obstruction in London and Chicago . Methods of treatment were much the same in the two clinics apart from a freer use of wide-spectrum antibiotics in London. The death rate was similar and the necropsy findings in those patients whose death could be directly attributed to their chest illness were also similar. A wide range of severity of emphysematous changes was found in patients from both clinics, from little or no emphysema to severe panacinar emphysema involving most of the lungs. We have already reported the relationships between clinical, physiological, and anatomical findings (Burrows et al., 1966) .
There were few differences in the course of the survivors in the two clinics. A higher proportion of Chicago patients claimed an improvement in their cough and dyspnoea, but the changes in objective tests were not significantly different in the two clinics. In the initial study a greater frequency of disabling 'chest illnesses' was found in London; this was fully confirmed in the present study. The more detailed three-monthly questionnaires revealed that the number of such illnesses were similar in the two groups, but that London patients spent more time off work and in bed. This is presumably related to various differences in social and economic conditions between the two cities, including working conditions, sickness benefits, and cost of treatment, but we have no evidence regarding the relative importance of such factors. However, it is possible that some of the differences between the clinics is due to more severe illness in London: the reported incidence of fever was slightly higher in British patients, but that of other symptomrs appeared to be similar.
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Type B (mild or absent emphysema) No radiological evidence of emphysema but with at least three of the following:
(1) sputum volume persistently more than 10 ml. /day; (2) persistent hypercapnia-defined as a Pco2
at least 6 mm. Hg above the level predicted from the F.E.V.1.0 (Burrows et al., 1965) ; (3) radiological evidence of chronic inflammatory disease in the lung parenchyma; (4) total lung capacity less than 100% predicted;
(5) diffusing capacity for CO not grossly reduced (DL/VA of 3 5 ml./min./mm. Hg./l. or more); (6) chronic or recurrent right heart failure. Type X (indeterminate) Patient cannot be designated as type A or B using the criteria.
